Age of Data at the Time of Publication of Contemporary Clinical Trials

JAMA Network Open

Volumn 1, Issue 4, 2018, Pages

  Welsh, John ^a   Lu, Yuan ^a,b   Dhruva, Sanket S ^b,c   Bikdeli, Behnood ^a,d,e   Desai, Nihar R ^a,b   Benchetrit, Liliya ^b   Zimmerman, Chloe O ^b   Mu, Lin ^b   Ross, Joseph S ^a,b,f   Krumholz, Harlan M ^a,b,f  

^a YALE NEW HAVEN HOSPITAL   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^d CARDIOVASCULAR RESEARCH FOUNDATION   (United States)

^e NewYork Presbyterian Hospital   (United States)

^f YALE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CHILD; CROSS-SECTIONAL STUDY; FEMALE; FOLLOW UP; GOVERNMENT; HUMAN; INTERNAL MEDICINE; LINEAR REGRESSION ANALYSIS; MALE; OUTCOME ASSESSMENT; PRESCHOOL CHILD; RANDOMIZED CONTROLLED TRIAL (TOPIC); SYSTEMATIC REVIEW; JOURNAL IMPACT FACTOR; METHODOLOGY; PUBLISHING; TIME FACTOR;

CROSS-SECTIONAL STUDIES; JOURNAL IMPACT FACTOR; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN; TIME FACTORS;

EID: 85054002332     PISSN: None     EISSN: 25743805     Source Type: Journal    
DOI: 10.1001/jamanetworkopen.2018.1065     Document Type: Article

References (15)

1. Mina A, Ramlogan R, Tampubolon G, Metcalfe JS. Mapping evolutionary trajectories: applications to the growth and transformation of medical knowledge. Res Policy. 2007; 36 (5): 789-806. doi: 10.1016/j.respol.2006.12.007
2. Dwan K, Gamble C, Williamson PR, Kirkham JJ; Reporting Bias Group. Systematic review of the empirical evidence of study publication bias and outcome reporting bias-an updated review. PLoS One. 2013; 8 (7): e66844. doi: 10.1371/journal.pone.0066844 23861749
3. Abrams JS, Mooney MM, Zwiebel JA, Implementation of timeline reforms speeds initiation of National Cancer Institute-sponsored trials. J Natl Cancer Inst. 2013; 105 (13): 954-959. doi: 10.1093/jnci/djt137 23776198
4. Ross JS, Mocanu M, Lampropulos JF, Tse T, Krumholz HM. Time to publication among completed clinical trials. JAMA Intern Med. 2013; 173 (9): 825-828. doi: 10.1001/jamainternmed.2013.136 23460252
5. Chen R, Desai NR, Ross JS, Publication and reporting of clinical trial results: cross sectional analysis across academic medical centers. BMJ. 2016; 352: i637. doi: 10.1136/bmj.i637 26888209
6. Clarivate Analytics. InCites journal citation reports. http://jcr.incites.thomsonreuters.com/JCRJournalHomeAction.action?Init=Yes&SrcApp=IC2LS&SID=H4-pnHECNan8PbZ7UBwLyceS23lBgxxQSzGL-18x2dUjuGpsN6XbQILyGpmx2Fh9wgx3Dx3DSVwcfQPbbNoJYKMXu6lkBwx3Dx3D-iyiHxxh55B2RtQWBj2LEuawx3Dx3D-1iOubBm4x2FSwJjjKtx2F7lAaQx3Dx3. Accessed November 20, 2017.
7. Packer M. Tetralogy of fallow: four trials and tribulations. JACC Heart Fail. 2017; 5 (6): 408-410. doi: 10.1016/j.jchf.2017.03.004 28501525
8. Packer M, Colucci W, Fisher L,; REVIVE Heart Failure Study Group. Effect of levosimendan on the short-term clinical course of patients with acutely decompensated heart failure. JACC Heart Fail. 2013; 1 (2): 103-111. doi: 10.1016/j.jchf.2012.12.004 24621834
9. Packer M, Carson P, Elkayam U,; PRAISE-2 Study Group. Effect of amlodipine on the survival of patients with severe chronic heart failure due to a nonischemic cardiomyopathy: results of the PRAISE-2 study (prospective randomized amlodipine survival evaluation 2). JACC Heart Fail. 2013; 1 (4): 308-314. doi: 10.1016/j.jchf.2013.04.004 24621933
10. Jones WS, Roe MT, Antman EM, The changing landscape of randomized clinical trials in cardiovascular disease. J Am Coll Cardiol. 2016; 68 (17): 1898-1907. doi: 10.1016/j.jacc.2016.07.781 27765193
11. Rao SV, Hess CN, Barham B, A registry-based randomized trial comparing radial and femoral approaches in women undergoing percutaneous coronary intervention: the SAFE-PCI for Women (Study of Access Site for Enhancement of PCI for Women) trial. JACC Cardiovasc Interv. 2014; 7 (8): 857-867. doi: 10.1016/j.jcin.2014.04.007 25147030
12. Hernandez AF, Fleurence RL, Rothman RL. The ADAPTABLE Trial and PCORnet: shining light on a new research paradigm. Ann Intern Med. 2015; 163 (8): 635-636. doi: 10.7326/M15-1460 doi: 10.7326/M15-1460 26301537
13. Smith SK, Selig W, Harker M, Patient engagement practices in clinical research among patient groups, industry, and academia in the United States: a survey. PLoS One. 2015; 10 (10): e0140232. doi: 10.1371/journal.pone.0140232 26465328
14. Selby JV, Slutsky JR. Practicing partnered research. J Gen Intern Med. 2014; 29 (suppl 4): 814-816. doi: 10.1007/s11606-014-3046-z 25355093
15. Ridker PM, MacFadyen JG, Thuren T, Everett BM, Libby P, Glynn RJ; CANTOS Trial Group. Effect of interleukin-1β inhibition with canakinumab on incident lung cancer in patients with atherosclerosis: exploratory results from a randomised, double-blind, placebo-controlled trial. Lancet. 2017; 390 (10105): 1833-1842. doi: 10.1016/S0140-6736(17)32247-X 28855077